Claim your 30% discount on Global Market Reports with code ONLINE30. Limited time only.

How Has the Metered Dose Inhaler Devices Market Size Changed, over the years?

The market for metered dose inhaler devices has seen robust expansion in the past years. It’s expected to increase from $15.46 billion in 2024 to a projected amount of $16.36 billion in 2025, demonstrating a compound annual growth rate (CAGR) of 5.8%. The historical growth can be linked to the rise in diabetes cases, the surge in demand for metered dose inhaler devices, the boost in production of these devices, and a higher incidence of COPD.

How Much Will the Metered Dose Inhaler Devices Market Be Worth in 2029?

Expectations are high for significant expansion in the metered dose inhaler devices market in the upcoming years, with the market poised to reach a value of $20.29 billion in 2029, growing at a compound annual growth rate (CAGR) of 5.5%. The projection for growth during this forecast period can be linked to the escalating incidents of chronic obstructive pulmonary diseases, a surge in asthma cases, a rise in infectious diseases, expanding prevalence of diabetes, and an increase in respiratory disease cases. The predicted trends during this period include technological breakthroughs, novel therapies, regulatory authorizations, introductions of new inhalers, and the utilization of internet-based marketing tools.

Download The Free Sample Report Here:

https://www.thebusinessresearchcompany.com/sample.aspx?id=20878&type=smp

Which is the Largest Company in the Metered Dose Inhaler Devices Market?

Major companies operating in the metered dose inhaler devices market are Pfizer Inc., Merck & Co. Inc., AstraZeneca PLC, GlaxoSmithKline plc, 3M Company, Boehringer Ingelheim GmbH, Teva Pharmaceutical Industries Ltd., Berry Global Inc., AptarGroup Inc., Philips Healthcare, Chiesi Farmaceutici S.p.A., Cipla Limited, Gerresheimer AG, Zydus Lifesciences Limited, Mylan N.V., Nemera, Beximco Pharmaceuticals Limited, Cohero Health Inc., Bespak Europe Ltd., Trudell Medical International, Iconovo AB

What Are the Main Market Drivers in the Metered Dose Inhaler Devices Industry?

The metered dose inhaler devices market is forecasted to expand, driven by the rising occurrences of chronic obstructive pulmonary diseases. Characterised by airflow blockage, chronic obstructive pulmonary disease (COPD) is a progressive lung condition often brought on by prolonged exposure to irritants such as cigarette smoke. Symptoms of this disease can include coughing, wheezing, and breathlessness. The escalating prevalence of COPD is influenced by factors such as aging populations, tobacco use, air pollution, and the delay in diagnosis or treatment. Metered dose inhaler (MDI) devices, which deliver medication directly to the lungs, thereby improving airflow and providing immediate relief, are pivotal in the management of COPD. As per the National Institutes of Health, a government agency in the USA, the incidence of COPD is anticipated to surge from 532 million in 2030 to a staggering 592 million by 2050. Hence, the growth of the metered dose inhaler devices market is being boosted by the rising prevalence of chronic obstructive pulmonary diseases.

Request For A Customized Report:

https://www.thebusinessresearchcompany.com/customise?id=20878&type=smp

How Is the Metered Dose Inhaler Devices Market Segments Structured?

The metered dose inhaler devices market covered in this report is segmented –

1) By Type: Desktop Metered Dose Inhaler Devices, Portable Metered Dose Inhaler Devices, Other Types

2) By Distribution Channel: Online, Offline

3) By Application: Asthma, Chronic Obstructive Pulmonary Disease, Other Applications

4) By End-User: Hospitals, Clinics, Homecare Settings, Other End Users

Subsegments:

1) By Desktop Metered Dose Inhaler Devices: Standard desktop MDI devices, High-performance desktop MDI devices, Smart desktop MDI devices

2) By Portable Metered Dose Inhaler Devices: Conventional portable MDI devices, Advanced portable MDI devices, Smart portable MDI devices

3) By Other Types: Nebulizer-Based MDI devices, Dry powder inhaler (DPI) combined devices, Soft mist inhaler (SMI) devices, Other specialized MDI devices

What Strategic Trends Are Transforming the Metered Dose Inhaler Devices Market?

Key businesses in the metered dose inhaler devices market are investing in the creation of cutting-edge techniques like pressurized metered dose inhalers, to boost drug distribution efficiency and increase patient adherence. Pressurized metered-dose inhalers (pMDIs) are breathing devices that dispense an exact quantity of medicine in aerosolized form made possible by a pressurized accelerant. For example, In July 2023, Lupin Limited, a pharmaceutical firm from India, released Luforbec 100/6 in Germany, a pMDI designed for adult asthma and chronic obstructive pulmonary disease (COPD) sufferers. This product blends beclometasone (100 µg) and formoterol (6 µg) to present a potent solution for patients in need of combination therapy. Importantly, Luforbec is approximately 47% cheaper than the stationary reference price, making it more accessible. Given that about 5% of adults in Germany are affected by asthma, this introduction emphasizes Lupin’s dedication to fulfilling urgent healthcare needs and enhancing respiratory care patient outcomes.

Access The Full Report Here:

https://www.thebusinessresearchcompany.com/report/metered-dose-inhaler-devices-global-market-report

Which Global Regions Offer the Highest Growth in the Metered Dose Inhaler Devices Market?

North America was the largest region in the metered dose inhaler devices market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the metered dose inhaler devices market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Purchase The Full Report Today:

https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=20878

This Report Delivers Insight On:

1. How big is the metered dose inhaler devices market, and how is it changing globally?

2. Who are the major companies in the metered dose inhaler devices market, and how are they performing?

3. What are the key opportunities and risks in the metered dose inhaler devices market right now?

4. Which products or customer segments are growing the most in the metered dose inhaler devices market?

5. What factors are helping or slowing down the growth of the metered dose inhaler devices market?

About The Business Research Company:

With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.

Get in touch with us:

The Business Research Company: https://www.thebusinessresearchcompany.com/

Americas +1 310-496-7795

Europe +44 7882 955267

Asia & Others +44 7882 955267 & +91 8897263534

Email us at info@tbrc.info

Follow us on:

LinkedIn: https://in.linkedin.com/company/the-business-research-company

YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model